DFine secures $35M to treat spinal fractures
Medical device maker DFine brought in $35 million in fourth round funding to develop and market its StabiliT Vertebral Augmentation System, a device that injects bone cement to heal fissures in patients’ spinal columns.
The original target amount for the round, $30 million, was reached in October. Investors include BB&T Fund, Highland Credit Strategies Fund, Prospect Venture Partners and Vanguard Ventures. The San Jose, Calif. company raised $18 million in previous investment rounds.
DFine stacks up $30M to mend spinal fractures
Healthcare developer DFine has brought in $30 million in fourth-round funding to commercialize a system to treat fractures in vertebrae caused by spine compression. Contributions came from BB&T Funds, Highland Capital Management, Prospect Venture Partners and Vanguard Ventures.
The San Jose, Calif. company has created an injection device, the StabiliT Vertebral Augmentation System, as well as human-safe StabiliT ER Bone Cement, to fill breaks. Osteoperosis, tumor growth and traumatic injury are the leading causes of the… Continue Reading